Christina P C Borba

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial
    Abebaw Fekadu
    Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
    Trials 14:406. 2013
  2. doi request reprint A qualitative study examining the perceived barriers and facilitators to medical healthcare services among women with a serious mental illness
    Christina P C Borba
    Rollins School of Public Health, Department of Behavioral Sciences and Health Education, Emory University, Atlanta, Georgia, USA
    Womens Health Issues 22:e217-24. 2012
  3. doi request reprint A day in the life of women with a serious mental illness: a qualitative investigation
    Christina P C Borba
    Department of Behavioral Sciences and Health Education, Emory University, Rollins School of Public Health, Atlanta, Georgia, USA
    Womens Health Issues 21:286-92. 2011
  4. pmc Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia
    Christina P C Borba
    Schizophrenia Program, Massachusetts General Hospital, Boston, MA, USA
    J Clin Psychopharmacol 31:653-8. 2011
  5. doi request reprint Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia
    David C Henderson
    Massachusetts General Hospital Schizophrenia Program, 25 Staniford Street, 2nd Floor, Boston, MA 02114, USA
    Schizophr Res 130:53-6. 2011
  6. pmc A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism
    Brenda Vincenzi
    Schizophrenia Clinical and Research Program, Massachusetts General Hospital, 25 Staniford Street, Boston, MA 02114, United States Electronic address
    Schizophr Res 159:395-403. 2014
  7. pmc Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine
    David C Henderson
    Schizophrenia Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Psychiatr Pract 15:251-61. 2009
  8. doi request reprint Open-label pilot study on vitamin D₃ supplementation for antipsychotic-associated metabolic anomalies
    Neelam Thakurathi
    Schizophrenia Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, USA
    Int Clin Psychopharmacol 28:275-82. 2013
  9. pmc Correlates of support for living donation among African American adults
    Dana H Z Robinson
    Rollins School of Public Health of Emory University, Atlanta, GA 30322, USA
    Prog Transplant 19:244-51. 2009
  10. pmc Capacity building in global mental health: professional training
    Gregory L Fricchione
    Harvard Medical School and Pierce Global Division, Department of Psychiatry, Massachusetts General Hospital, Boston 02114, USA
    Harv Rev Psychiatry 20:47-57. 2012

Collaborators

Detail Information

Publications10

  1. pmc Adjuvant therapy with minocycline for schizophrenia (The MINOS Trial): study protocol for a double-blind randomized placebo-controlled trial
    Abebaw Fekadu
    Department of Psychiatry, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
    Trials 14:406. 2013
    ..In this study we aim to assess the efficacy of adjunctive minocycline to alleviate symptoms of schizophrenia in patients who have failed to respond to a therapeutic trial of antipsychotic medications...
  2. doi request reprint A qualitative study examining the perceived barriers and facilitators to medical healthcare services among women with a serious mental illness
    Christina P C Borba
    Rollins School of Public Health, Department of Behavioral Sciences and Health Education, Emory University, Atlanta, Georgia, USA
    Womens Health Issues 22:e217-24. 2012
    ..This qualitative study investigates the barriers and facilitators to accessing and utilizing healthcare services among women with a serious mental illness (SMI)...
  3. doi request reprint A day in the life of women with a serious mental illness: a qualitative investigation
    Christina P C Borba
    Department of Behavioral Sciences and Health Education, Emory University, Rollins School of Public Health, Atlanta, Georgia, USA
    Womens Health Issues 21:286-92. 2011
    ..This qualitative study of women with an SMI describes and interprets women's experiences and provides a new understanding about the nature and needs of these women...
  4. pmc Placebo-controlled pilot study of ramelteon for adiposity and lipids in patients with schizophrenia
    Christina P C Borba
    Schizophrenia Program, Massachusetts General Hospital, Boston, MA, USA
    J Clin Psychopharmacol 31:653-8. 2011
    ..We now report a randomized placebo-controlled pilot study to examine the effects of ramelteon on obesity and metabolic disturbances among subjects with schizophrenia...
  5. doi request reprint Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia
    David C Henderson
    Massachusetts General Hospital Schizophrenia Program, 25 Staniford Street, 2nd Floor, Boston, MA 02114, USA
    Schizophr Res 130:53-6. 2011
    ..Modafinil has been proposed as a treatment for clozapine-induced sedation and metabolic abnormalities...
  6. pmc A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism
    Brenda Vincenzi
    Schizophrenia Clinical and Research Program, Massachusetts General Hospital, 25 Staniford Street, Boston, MA 02114, United States Electronic address
    Schizophr Res 159:395-403. 2014
    ..The aim of this study was to investigate the role of pravastatin, as an adjunctive therapy, on inflammatory markers, lipid and glucose metabolism, psychopathology, and cognition in subjects with schizophrenia and schizoaffective disorder...
  7. pmc Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine
    David C Henderson
    Schizophrenia Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
    J Psychiatr Pract 15:251-61. 2009
    ....
  8. doi request reprint Open-label pilot study on vitamin D₃ supplementation for antipsychotic-associated metabolic anomalies
    Neelam Thakurathi
    Schizophrenia Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, USA
    Int Clin Psychopharmacol 28:275-82. 2013
    ....
  9. pmc Correlates of support for living donation among African American adults
    Dana H Z Robinson
    Rollins School of Public Health of Emory University, Atlanta, GA 30322, USA
    Prog Transplant 19:244-51. 2009
    ..Examination of barriers to living donation can lead to effective strategies to educate dialysis patients and their families about this alternative...
  10. pmc Capacity building in global mental health: professional training
    Gregory L Fricchione
    Harvard Medical School and Pierce Global Division, Department of Psychiatry, Massachusetts General Hospital, Boston 02114, USA
    Harv Rev Psychiatry 20:47-57. 2012
    ..In sum, this article discusses human capacity building in global mental health, provides recommendations for training, and offers examples of recent initiatives...